Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.99% | 156.12 | 0.7% | $1332.58m | |
| PFE | Pfizer Inc. | 0.50% | 34.37 | 0.9% | $1246.54m | |
| BMY | Bristol-Myers Squibb Co. | 1.75% | 60.38 | 1.0% | $850.51m | |
| MRK | Merck & Co., Inc. | 1.34% | 73.14 | 0.7% | $824.91m | |
| ABBV | AbbVie, Inc. | 0.99% | 106.70 | 1.9% | $789.53m | |
| LLY | Eli Lilly & Co. | 3.13% | 206.81 | 1.1% | $757.17m | |
| AZN | AstraZeneca Plc | 1.76% | 48.06 | 1.2% | $496.61m | |
| GSK | GlaxoSmithKline Plc | 1.84% | 34.91 | 0.2% | $279.35m | |
| SNY | Sanofi | 1.50% | 46.59 | 0.2% | $173.19m | |
| NVS | Novartis AG | 0.64% | 84.03 | 0.2% | $172.81m | |
| VTRS | Viatris, Inc. | 2.36% | 13.91 | 0.0% | $134.20m | |
| VERU | Veru, Inc. | 1.15% | 12.33 | 0.0% | $101.62m | |
| CVAC | CureVac NV | 1.67% | 82.69 | 0.0% | $94.10m | |
| NVO | Novo Nordisk A/S | 0.58% | 69.62 | 0.1% | $88.53m | |
| KALV | KalVista Pharmaceuticals, Inc. | -2.16% | 30.88 | 0.4% | $79.85m |
Company Profile
LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.